These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prognostic Value of Hepatocyte Growth Factor Receptor Expression in Patients with Perihilar Cholangiocarcinoma. Watanabe H; Yokoyama Y; Kokuryo T; Ebata T; Igami T; Sugawara G; Mizuno T; Shimoyama Y; Nagino M Ann Surg Oncol; 2015 Jul; 22(7):2235-42. PubMed ID: 25586241 [TBL] [Abstract][Full Text] [Related]
4. Expression of E-cadherin and β-catenin in two cholangiocarcinoma cell lines (OZ and HuCCT1) with different degree of invasiveness of the primary tumor. Abuetabh Y; Persad S; Nagamori S; Huggins J; Al-Bahrani R; Sergi C Ann Clin Lab Sci; 2011; 41(3):217-23. PubMed ID: 22075503 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of macrophage invasion in hilar cholangiocarcinoma. Atanasov G; Hau HM; Dietel C; Benzing C; Krenzien F; Brandl A; Wiltberger G; Matia I; Prager I; Schierle K; Robson SC; Reutzel-Selke A; Pratschke J; Schmelzle M; Jonas S BMC Cancer; 2015 Oct; 15():790. PubMed ID: 26497197 [TBL] [Abstract][Full Text] [Related]
9. SPARCL1 is a novel predictor of tumor recurrence and survival in hilar cholangiocarcinoma. Yu Y; Chen Y; Ma J; Yu X; Yu G; Li Z Tumour Biol; 2016 Mar; 37(3):4159-67. PubMed ID: 26490986 [TBL] [Abstract][Full Text] [Related]
10. Primary neuroendocrine tumor of the extrahepatic biliary tree mimicking Klatskin tumor. Tsalis K; Vrakas G; Geroukis T; Cheva A; Roidos GN; Lazarides C J Gastrointestin Liver Dis; 2010 Sep; 19(3):341-2. PubMed ID: 20922208 [No Abstract] [Full Text] [Related]
11. Intraductal ultrasonography combined with percutaneous transhepatic cholangioscopy for the preoperative evaluation of longitudinal tumor extent in hilar cholangiocarcinoma. Kim HM; Park JY; Kim KS; Park MS; Kim MJ; Park YN; Bang S; Song SY; Chung JB; Park SW J Gastroenterol Hepatol; 2010 Feb; 25(2):286-92. PubMed ID: 19780880 [TBL] [Abstract][Full Text] [Related]
12. Surgery for perihilar cholangiocarcinoma. Groot Koerkamp B; Jarnagin WR Br J Surg; 2018 Jun; 105(7):771-772. PubMed ID: 29756647 [No Abstract] [Full Text] [Related]
13. [Pathological anatomical characteristics of Klatskin tumors. Classification, current molecular biological aspects, prognosis factors]. Munding J; Tannapfel A Chirurg; 2012 Mar; 83(3):208-14. PubMed ID: 22290222 [TBL] [Abstract][Full Text] [Related]
14. Fascin expression is correlated with tumor progression of extrahepatic bile duct cancer. Okada K; Shimura T; Asakawa K; Hashimoto S; Mochida Y; Suehiro T; Kuwano H Hepatogastroenterology; 2007; 54(73):17-21. PubMed ID: 17419223 [TBL] [Abstract][Full Text] [Related]
15. Can unilateral stent placement be adequate in patients with Klatskin tumors of Bismuth-type III and IV? Shah SK; Costamagna G Gastrointest Endosc; 2001 Dec; 54(6):804-5. PubMed ID: 11726870 [No Abstract] [Full Text] [Related]
16. Colonic metastasis of Klatskin tumor: case report and discussion of the current literature. Schmeding M; Neumann U; Neuhaus P World J Gastroenterol; 2006 Sep; 12(33):5393-5. PubMed ID: 16981275 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of Prdx1 in hilar cholangiocarcinoma: a predictor for recurrence and prognosis. Zhou J; Shen W; He X; Qian J; Liu S; Yu G Int J Clin Exp Pathol; 2015; 8(9):9863-74. PubMed ID: 26617696 [TBL] [Abstract][Full Text] [Related]
19. Neuroendocrine Carcinoma of the Gallbladder Masquerading as a Klatskin Tumor in a 74-Year-Old Male. Kütting F; Schmidt M; Waldschmidt D; Curth H; Schramm C; Steffen HM J Gastrointest Cancer; 2016 Mar; 47(1):118-22. PubMed ID: 26036328 [No Abstract] [Full Text] [Related]
20. TWIST1 and SNAI1 as markers of poor prognosis in human colorectal cancer are associated with the expression of ALDH1 and TGF-β1. Kim YH; Kim G; Kwon CI; Kim JW; Park PW; Hahm KB Oncol Rep; 2014 Mar; 31(3):1380-8. PubMed ID: 24402192 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]